Ficellomycin can be used in the research of various bacterial diseases; it exhibits high in vitro activity against Gram-positive bacteria, including multidrug-resistant strains of Staphylococcus aureus, by impairing semi-conservative DNA replication through the induction of defective 34S DNA fragments that lack the ability to integrate into larger DNA fragments and ultimately form intact bacterial chromosomes.